PARLIAMENTARY WRITTEN QUESTION
Coronavirus: Vaccination (2 July 2021)

To ask the Secretary of State for Health and Social Care, what steps his Department has taken to ensure long-term immune monitoring of people who have received different covid-19 vaccines for each dose.

Asked by:
Marsha De Cordova (Labour)

The National Institute for Health Research has commissioned the National Immunisation Schedule Evaluation Consortium to undertake the Com-CoV trial. This trial is gathering data on the long-term immune response of using different COVID-19 vaccines for the first and second dose. Public Health England has also undertaken follow up on people given mixed schedules as part of routine care to monitor self-reported side effects and antibody response. The results will be published in due course. Current guidance recommends every effort should be made to complete the course with the same vaccine unless there are specific circumstances in which this is not appropriate.

Answered by:
Nadhim Zahawi (Conservative)
12 July 2021